Integer Holdings
ITGR
126.59
+0.12
+0.09%
Integer Holdings
US · ITGR
#2239 by market cap
Listed 1970
126.59
+0.12
+0.09%
Live - 5344 symbols - heartbeat 363s ago
· 2026-10-07 19:54
After-hours
126.57
-0.02%
- Market cap
- 4.30B
- P/E (TTM)i
- 34.68
- P/Bi
- 2.50
- EPSi
- 2.89
- Div yieldi
- 0.00%
- 52W posi
- 100%
Reader sentiment
Are you bullish or bearish on ITGR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.9 percentage points.
Institutional ownership
- Held by institutions
- 121.08% -0.85pp
- Institutions
- 386 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund83.92%
Hedge Fund14.86%
Public Company14.51%
Private Company3.56%
Government Pension Fund3.56%
Individual/Insider0.98%
Insurance Company0.33%
Family Office/Trust0.17%
Sovereign Wealth Fund0.15%
Top holders as of 2026-06-30
BlackRock
15.75% · 5.35M sh
Invesco Ltd.
6.28% · 2.13M sh
Vanguard Portfolio Management, LLC
6.00% · 2.04M sh
Vanguard Capital Management, LLC
5.17% · 1.76M sh
Dimensional Fund Advisors
4.79% · 1.63M sh
Nomura Holdings, Inc.
4.57% · 1.55M sh
State Street Global Advisors
4.16% · 1.41M sh
Irenic Capital Management LP
3.72% · 1.26M sh
EARNEST Partners, LLC
2.97% · 1.01M sh
Hudson Bay Capital Management LP
2.94% · 1.00M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 27 buys · 22 sells
| Name | Role | Stake |
|---|---|---|
| Payman Khales | President of Cardio & Vascular | 0.18% |
| Pamela Bailey | Independent Chairperson | 0.16% |
| William Summers | Independent Director | 0.13% |
| Filippo Passerini | Independent Director | 0.09% |
| M. Maxwell | Independent Director | 0.07% |
| Donald Spence | Independent Director | 0.06% |
| Diron Smith | Chief Financial Officer | 0.04% |
| Cheryl Capps | Independent Director | 0.03% |
| Sheila Antrum | Independent Director | 0.03% |
| John Harris | Former Vice President of Operations - Cardio & Vascular | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-14 | Kirk Thor | Executive Vice President | Open Market Disposition | -31,540 | $126.23–126.25 |
| 2026-09-14 | Kirk Thor | Executive Vice President | Intent to Sell (Form 144) | -4,700 | $126.30 |
| 2026-09-10 | Kirk Thor | Executive Vice President | Intent to Sell (Form 144) | -31,540 | $126.20 |
| 2026-09-07 | Andrew Senn | Senior Vice President of Strategy, Business Development & Investor Relations | Open Market Disposition | -9,408 | $126.30 |
| 2026-06-29 | Kirk Thor | Executive Vice President | Derivative Exercise and Sale | -2,409 | $93.45 |
| 2026-06-29 | Kirk Thor | Executive Vice President | Derivative Exercise and Retained | +3,711 | -- |
| 2026-06-28 | John Harris | Former Vice President of Operations - Cardio & Vascular | Other Derivative Acquisition | +1,096 | -- |
| 2026-05-19 | Michael Coyle | Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Filippo Passerini | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | M. Maxwell | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | James Hinrichs | Independent Director | Other Derivative Acquisition | +1,967 | -- |
| 2026-05-19 | Donald Spence | Independent Director | Other Derivative Acquisition | +2,623 | -- |
| 2026-05-19 | James Flanagan | Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Sheila Antrum | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Alvin Jeffers | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Cheryl Capps | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Aaron Kapito | Director | Other Acquisition | +1,967 | -- |
| 2026-05-17 | Tom Thomas | VP, Corporate Controller & Principal Accounting Officer | Other Derivative Acquisition | +666 | -- |
| 2026-05-14 | Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | Derivative Exercise and Sale | -479 | $88.16 |
| 2026-05-14 | Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | Derivative Exercise and Retained | +1,484 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.